FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37800211000001108: Upadacitinib (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    444251000001115 Upadacitinib en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    444261000001117 Upadacitinib (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Upadacitinib Is a Substance with Janus kinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Upadacitinib hemihydrate Is a False Upadacitinib Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier
    Upadacitinib 15mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier
    Upadacitinib 15mg modified-release tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Upadacitinib Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start